{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T14:20:43Z","timestamp":1782742843499,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"DOI":"10.1186\/s12937-025-01170-0","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:53:50Z","timestamp":1751378030000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Machine learning models integrating dietary data predict all-cause mortality in U.S. NAFLD patients: an NHANES-based study"],"prefix":"10.1186","volume":"24","author":[{"given":"Pinchu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfenglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"1170_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320. https:\/\/doi.org\/10.1038\/nrgastro.2017.109.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"1170_CR2","doi-asserted-by":"publisher","first-page":"103910","DOI":"10.1016\/j.drudis.2024.103910","volume":"29","author":"S Wei","year":"2024","unstructured":"Wei S, Wang L, Evans PC, Xu S. NAFLD and NASH: etiology, targets and emerging therapies. Drug Discov Today. 2024;29(3):103910. https:\/\/doi.org\/10.1016\/j.drudis.2024.103910.","journal-title":"Drug Discov Today"},{"issue":"10290","key":"1170_CR3","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VWS, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397(10290):2212\u201324. https:\/\/doi.org\/10.1016\/S0140-6736(20)32511-3.","journal-title":"Lancet"},{"issue":"3","key":"1170_CR4","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - A global public health perspective. J Hepatol. 2019;70(3):531\u201344. https:\/\/doi.org\/10.1016\/j.jhep.2018.10.033.","journal-title":"J Hepatol"},{"issue":"5","key":"1170_CR5","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1210\/er.2019-00034","volume":"40","author":"MJ Watt","year":"2019","unstructured":"Watt MJ, Miotto PM, De Nardo W, Montgomery MK. The liver as an endocrine Organ-Linking NAFLD and insulin resistance. Endocr Rev. 2019;40(5):1367\u201393. https:\/\/doi.org\/10.1210\/er.2019-00034.","journal-title":"Endocr Rev"},{"issue":"4","key":"1170_CR6","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","volume":"69","author":"C Estes","year":"2018","unstructured":"Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in china, france, germany, italy, japan, spain, united kingdom, and united States for the period 2016\u20132030. J Hepatol. 2018;69(4):896\u2013904. https:\/\/doi.org\/10.1016\/j.jhep.2018.05.036.","journal-title":"J Hepatol"},{"issue":"9","key":"1170_CR7","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1111\/liv.15046","volume":"42","author":"T Nakatsuka","year":"2022","unstructured":"Nakatsuka T, Tateishi R, Koike K. Changing clinical management of NAFLD in Asia. Liver Int. 2022;42(9):1955\u201368. https:\/\/doi.org\/10.1111\/liv.15046.","journal-title":"Liver Int"},{"issue":"1 Suppl","key":"1170_CR8","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47\u201364. https:\/\/doi.org\/10.1016\/j.jhep.2014.12.012.","journal-title":"J Hepatol"},{"issue":"9","key":"1170_CR9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/gutjnl-2020-320622","volume":"69","author":"G Targher","year":"2020","unstructured":"Targher G, Byrne CD, Tilg H. NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and Pharmacological implications. Gut. 2020;69(9):1691\u2013705. https:\/\/doi.org\/10.1136\/gutjnl-2020-320622.","journal-title":"Gut"},{"key":"1170_CR10","doi-asserted-by":"publisher","first-page":"1141156","DOI":"10.3389\/fnut.2023.1141156","volume":"10","author":"B Yao","year":"2023","unstructured":"Yao B, Lu X, Xu L, Jiang Y. Association of serum folate with prevalence of non-alcoholic fatty liver disease among adults (NHANES 2011\u20132018). Front Nutr. 2023;10:1141156. https:\/\/doi.org\/10.3389\/fnut.2023.1141156.","journal-title":"Front Nutr"},{"issue":"1","key":"1170_CR11","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1038\/s41598-024-52077-5","volume":"14","author":"C Liu","year":"2024","unstructured":"Liu C, Sun X, Peng J, Yu H, Lu J, Feng Y. Association between dietary vitamin A intake from different sources and non-alcoholic fatty liver disease among adults. Sci Rep. 2024;14(1):1851. https:\/\/doi.org\/10.1038\/s41598-024-52077-5.","journal-title":"Sci Rep"},{"issue":"24","key":"1170_CR12","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/nu14245335","volume":"14","author":"W Guo","year":"2022","unstructured":"Guo W, Ge X, Lu J, et al. Diet and risk of Non-Alcoholic fatty liver disease, cirrhosis, and liver cancer: A large prospective cohort study in UK biobank. Nutrients. 2022;14(24):5335. https:\/\/doi.org\/10.3390\/nu14245335.","journal-title":"Nutrients"},{"issue":"19","key":"1170_CR13","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.3390\/nu15194128","volume":"15","author":"J Pan","year":"2023","unstructured":"Pan J, Hu Y, Pang N, Yang L. Association between dietary niacin intake and nonalcoholic fatty liver disease: NHANES 2003\u20132018. Nutrients. 2023;15(19):4128. https:\/\/doi.org\/10.3390\/nu15194128.","journal-title":"Nutrients"},{"issue":"2","key":"1170_CR14","doi-asserted-by":"publisher","first-page":"e2354277","DOI":"10.1001\/jamanetworkopen.2023.54277","volume":"7","author":"J Pan","year":"2024","unstructured":"Pan J, Zhou Y, Pang N, Yang L. Dietary niacin intake and mortality among individuals with nonalcoholic fatty liver disease. JAMA Netw Open. 2024;7(2):e2354277. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.54277.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"1170_CR15","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00394-023-03179-9","volume":"62","author":"Y Bai","year":"2023","unstructured":"Bai Y, Li T, Liu J, et al. Aerobic exercise and vitamin E improve high-fat diet-induced NAFLD in rats by regulating the AMPK pathway and oxidative stress. Eur J Nutr. 2023;62(6):2621\u201332. https:\/\/doi.org\/10.1007\/s00394-023-03179-9.","journal-title":"Eur J Nutr"},{"issue":"3","key":"1170_CR16","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1007\/s00535-017-1415-1","volume":"53","author":"Y Sumida","year":"2018","unstructured":"Sumida Y, Yoneda M. Current and future Pharmacological therapies for NAFLD\/NASH. J Gastroenterol. 2018;53(3):362\u201376. https:\/\/doi.org\/10.1007\/s00535-017-1415-1.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1170_CR17","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.3390\/nu14061224","volume":"14","author":"L Li","year":"2022","unstructured":"Li L, Huang Q, Yang L, et al. The association between Non-Alcoholic fatty liver disease (NAFLD) and advanced fibrosis with serological vitamin B12 markers: results from the NHANES 1999\u20132004. Nutrients. 2022;14(6):1224. https:\/\/doi.org\/10.3390\/nu14061224.","journal-title":"Nutrients"},{"key":"1170_CR18","doi-asserted-by":"publisher","first-page":"117210","DOI":"10.1016\/j.ecoenv.2024.117210","volume":"286","author":"Q Fu","year":"2024","unstructured":"Fu Q, Wu Y, Zhu M, et al. Identifying cardiovascular disease risk in the U.S. Population using environmental volatile organic compounds exposure: A machine learning predictive model based on the SHAP methodology. Ecotoxicol Environ Saf. 2024;286:117210. https:\/\/doi.org\/10.1016\/j.ecoenv.2024.117210.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"4","key":"1170_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jhep.2008.06.018","volume":"49","author":"JP Ong","year":"2008","unstructured":"Ong JP, Pitts A, Younossi ZM. Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease. J Hepatol. 2008;49(4):608\u201312. https:\/\/doi.org\/10.1016\/j.jhep.2008.06.018.","journal-title":"J Hepatol"},{"issue":"10","key":"1170_CR20","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1111\/apt.18242","volume":"60","author":"EY Lee","year":"2024","unstructured":"Lee EY, Nguyen VH, Cheung R, Nguyen MH. Trends of chronic liver diseases by income level and socioeconomic factors in the united states: A population-based study. Aliment Pharmacol Ther. 2024;60(10):1374\u201387. https:\/\/doi.org\/10.1111\/apt.18242.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"1170_CR21","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","volume":"22","author":"S Jimba","year":"2005","unstructured":"Jimba S, Nakagami T, Takahashi M, et al. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults. Diabet Med. 2005;22(9):1141\u20135. https:\/\/doi.org\/10.1111\/j.1464-5491.2005.01582.x.","journal-title":"Diabet Med"},{"issue":"7","key":"1170_CR22","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00392-020-01709-7","volume":"110","author":"P Kasper","year":"2021","unstructured":"Kasper P, Martin A, Lang S, et al. NAFLD and cardiovascular diseases: a clinical review. Clin Res Cardiol. 2021;110(7):921\u201337. https:\/\/doi.org\/10.1007\/s00392-020-01709-7.","journal-title":"Clin Res Cardiol"},{"issue":"8","key":"1170_CR23","doi-asserted-by":"publisher","first-page":"e3333","DOI":"10.1002\/dmrr.3333","volume":"36","author":"TV Fiorentino","year":"2020","unstructured":"Fiorentino TV, Succurro E, Sciacqua A, Andreozzi F, Perticone F, Sesti G. Non-alcoholic fatty liver disease is associated with cardiovascular disease in subjects with different glucose tolerance. Diabetes Metab Res Rev. 2020;36(8):e3333. https:\/\/doi.org\/10.1002\/dmrr.3333.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"1170_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.cgh.2016.07.031","volume":"15","author":"D Houghton","year":"2017","unstructured":"Houghton D, Thoma C, Hallsworth K, et al. Exercise reduces liver lipids and visceral adiposity in patients with nonalcoholic steatohepatitis in a randomized controlled trial. Clin Gastroenterol Hepatol. 2017;15(1):96\u2013e1023. https:\/\/doi.org\/10.1016\/j.cgh.2016.07.031.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1170_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1016\/j.cgh.2020.07.023","volume":"19","author":"D Kim","year":"2021","unstructured":"Kim D, Murag S, Cholankeril G, et al. Physical activity, measured objectively, is associated with lower mortality in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2021;19(6):1240\u2013e1247. https:\/\/doi.org\/10.1016\/j.cgh.2020.07.023.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"1170_CR26","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/MCO.0000000000000696","volume":"23","author":"M Dayib","year":"2020","unstructured":"Dayib M, Larson J, Slavin J. Dietary fibers reduce obesity-related disorders: mechanisms of action. Curr Opin Clin Nutr Metab Care. 2020;23(6):445\u201350. https:\/\/doi.org\/10.1097\/MCO.0000000000000696.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"27","key":"1170_CR27","doi-asserted-by":"publisher","first-page":"8752","DOI":"10.1080\/10408398.2022.2061909","volume":"63","author":"IS Waddell","year":"2023","unstructured":"Waddell IS, Orfila C. Dietary fiber in the prevention of obesity and obesity-related chronic diseases: from epidemiological evidence to potential molecular mechanisms. Crit Rev Food Sci Nutr. 2023;63(27):8752\u201367. https:\/\/doi.org\/10.1080\/10408398.2022.2061909.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"1170_CR28","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.ajcnut.2023.11.013","volume":"119","author":"YC Chooi","year":"2024","unstructured":"Chooi YC, Zhang QA, Magkos F, et al. Effect of an Asian-adapted mediterranean diet and Pentadecanoic acid on fatty liver disease: the TANGO randomized controlled trial. Am J Clin Nutr. 2024;119(3):788\u201399. https:\/\/doi.org\/10.1016\/j.ajcnut.2023.11.013.","journal-title":"Am J Clin Nutr"},{"issue":"20","key":"1170_CR29","doi-asserted-by":"publisher","first-page":"4310","DOI":"10.3390\/nu14204310","volume":"14","author":"D Maciejewska-Markiewicz","year":"2022","unstructured":"Maciejewska-Markiewicz D, Drozd A, Palma J, et al. Fatty acids and eicosanoids change during High-Fiber diet in NAFLD Patients-Randomized control trials (RCT). Nutrients. 2022;14(20):4310. https:\/\/doi.org\/10.3390\/nu14204310.","journal-title":"Nutrients"},{"issue":"1","key":"1170_CR30","doi-asserted-by":"publisher","first-page":"e1900580","DOI":"10.1002\/mnfr.201900580","volume":"65","author":"ZM Kundi","year":"2021","unstructured":"Kundi ZM, Lee JCY, Pihlajam\u00e4ki J, et al. Dietary Fiber from oat and Rye Brans ameliorate Western Diet-Induced body weight gain and hepatic inflammation by the modulation of Short-Chain fatty acids, bile acids, and Tryptophan metabolism. Mol Nutr Food Res. 2021;65(1):e1900580. https:\/\/doi.org\/10.1002\/mnfr.201900580.","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"1170_CR31","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/j.1478-3231.2011.02730.x","volume":"32","author":"JA Parnell","year":"2012","unstructured":"Parnell JA, Raman M, Rioux KP, Reimer RA. The potential role of prebiotic fibre for treatment and management of non-alcoholic fatty liver disease and associated obesity and insulin resistance. Liver Int. 2012;32(5):701\u201311. https:\/\/doi.org\/10.1111\/j.1478-3231.2011.02730.x.","journal-title":"Liver Int"},{"issue":"17","key":"1170_CR32","doi-asserted-by":"publisher","first-page":"2956","DOI":"10.3390\/nu16172956","volume":"16","author":"JI Mart\u00edn Barraza","year":"2024","unstructured":"Mart\u00edn Barraza JI, Bars-Cortina D. Dietary pattern\u2019s role in hepatic epigenetic and dietary recommendations for the prevention of NAFLD. Nutrients. 2024;16(17):2956. https:\/\/doi.org\/10.3390\/nu16172956.","journal-title":"Nutrients"},{"issue":"1","key":"1170_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s13148-022-01377-6","volume":"14","author":"KE Sokolowska","year":"2022","unstructured":"Sokolowska KE, Maciejewska-Markiewicz D, Bi\u0144kowski J, et al. Identified in blood diet-related methylation changes stratify liver biopsies of NAFLD patients according to fibrosis grade. Clin Epigenetics. 2022;14(1):157. https:\/\/doi.org\/10.1186\/s13148-022-01377-6.","journal-title":"Clin Epigenetics"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01170-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12937-025-01170-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-025-01170-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:53:50Z","timestamp":1751378030000},"score":1,"resource":{"primary":{"URL":"https:\/\/nutritionj.biomedcentral.com\/articles\/10.1186\/s12937-025-01170-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1170"],"URL":"https:\/\/doi.org\/10.1186\/s12937-025-01170-0","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"23 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"We used AI to polish the manuscript. Apart from this, no other AI tools were utilized.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"AI Statement"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The research was carried out in compliance with the ethical principles outlined in the Declaration of Helsinki. All study procedures involving human participants were reviewed and approved by the Institutional Review Board of the National Center for Health Statistics (NCHS). Additionally, written informed consent was secured from each participant\/patient involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}